Genomic Sequencing Services for the NIAID Centralized Sequencing Initiative

Closed Solicitation Posted

Solicitation number
RFQ-RML-D-1978596
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

NAICS code
541380 Testing Laboratories and Services
PSC
Not on record
Place of performance
NIH 9000 Rockville Pike Bldg 10 Clinical Center Bethesda, Maryland 20892, United States

Notice details come from SAM.gov. Updated .

Notice text

3 versions

Update #3 · Latest ·

***SUBMISSION DEADLINE EXTENDED TO SEPTEMBER 11, 2019 5:00 EST***
RFQ SUPPLEMENTAL DOCUMENT (ADDITIONAL INFORMATION FOR SOW) ATTACHED!

.

Update #2 ·

LINE ITEMS & QUANTITIES
# Description Qty at Price
1 Clinical whole exome sequencing with UTRs 1750 each at $

2 Clinical whole genome sequencing 25 each at $


3 RNA Seq on human samples 25 each at $


4 Clinical Whole Exome Sequencing- rapid exomes 25 each at $
5 Chromosomal Microarray Analysis 200 each at $


.

Update #1 ·

This notice is a combined synopsis/solicitation for commercial items using Simplified Acquisition Procedures. This acquisition will be made in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 "Streamlined Procedures for Evaluation and solicitation for commercial Items," as applicable, and as supplemented with additional information included in this notice. This announcement constitutes the only solicitation (a written solicitation will not be issued) and quotes are being requested. The Solicitation number is RFQ-RML-D-1978596 and the solicitation is issued as a Request for Quotes (RFQ).


This acquisition will be processed under FAR Part 13.5 Simplified Acquisition Procedures (SAP). The solicitation documents and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2019-05 August 13, 2019.


The North American Industry Classification System (NAICS) code for this procurement is 541380, Testing Laboratories, with a small business size standard of $15 million. The requirement is being competed full and open competition, un-restricted and without a small business set-aside.


The purpose of this acquisition is to obtain genetic testing for the National Institutes of Allergy & Infectious Diseases (NIAID) Centralized Sequencing Initiative (CSI). The goal of CSI is to obtain genetic testing results for all NIAID patients enrolled in clinical trials at the NIH Clinical Center.


The types of sequencing required for the initiative are; Whole Exome Sequencing (WES), custom microarrays for Comparative Genomic Hybridization (CGH), and Whole Genome Sequencing (WGS) coupled with RNAseq. Exome and genome sequencing allow for discovery of monogenic and polygenic contributions to immune system disorders and CGH microarray sequencing will provide analysis of over 2000 target genes selected by NIAID that cause, or are suspected to cause, immunological diseases in the patient population.
*** SEQUENCING SERVICES MUST MEET SPECIFICATIONS OUTLINED IN THE ATTACHED STATEMENT OF WORK (see: attachment SOW).


Place of Performance: NIH, 9000 Rockville Pike, BLDG 10 Clinical Center, Bethesda, MD 20852, United States. FOB: Destination


The government intends to award a firm fixed price purchase order to the responsible contractor as a result of this RFQ that will include the terms and conditions set forth herein. The award will be based on the following; technical capability to meet the requirements and price.



The following FAR provisions apply to this acquisition:


FAR 52.212-1 Instructions to Offerors Commercial Items (Oct 2018)


FAR 52.212-3 Offerors Representations and Certifications - Commercial Items (Oct 2018)


FAR 52.204-7 System for Award Management (Oct 2018)


(Offerors must complete annual representations and certifications on-line at http://www.sam.gov/ in accordance with FAR 52.212-3 Offerors Representations and Certifications- Commercial Items (Please ensure 52.209-2 -- Prohibition on Contracting with Inverted Domestic Corporations--Representation. (Nov 2015) is updated in your SAM record)


FAR 52.204-16 Commercial and Government Entity Code Reporting (July 2016)


FAR 52.203-18 Prohibition on Contracting with Entities that Require Certain Internal Confidentiality Agreements - Representation (Jan 2017)


52.204-24 Representation Regarding Certain Telecommunications and Video
Surveillance Services or Equipment (August 2019) *** Must complete representation - (see: attachment 52.204-24)


FAR 52.209-7 Information regarding Responsibility Matters (October 2018)



The following FAR contract clauses apply to this acquisition:


FAR 52-212-4 Contract Terms and Conditions Commercial Items (August 2019)


FAR 52-212.5 Contract Terms and Conditions Required to Implement Statutes or Executive Orders Commercial Items (August 2019)
*The applicable subparagraphs of FAR52.212-5 are included in the attachment to this posting.


FAR 52.232-40 Providing Accelerated Payments to Small Business Subcontractors (Dec 2013)


FAR 52.204-13 System for Award Management Maintenance (Oct 2018)


FAR 52.204-18 Commercial and Government Entity Code Maintenance (July 2016)


HHSAR 352.222-70, Contractor Cooperation in Equal Employment Opportunity Investigations (December 2015)


52.252-2 -- Clauses Incorporated by Reference. (Feb 1998)
This contract incorporates one or more clauses by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. Also, the full text of a clause may be accessed electronically at this address: http://farsite.hill.af.mil/vffara.htm



By submission of an offer, the offeror acknowledges the requirement that a prospective awardee shall be registered in the System for Award Management (SAM) database prior to award, during performance, and through final payment of any contract, basic agreement, basic ordering agreement, or blanket purchasing agreement resulting from this solicitation (www.sam.gov).


Copies of the above-referenced provisions and clauses are available from http://www.acquisition.gov/far/loadmainre.html & http: //www.hhs.gov/regulation/index.html or, upon request, either by telephone or fax.



Submission shall be received not later than September 09, 2019 @ 5:00 EST


Offers may be e-mailed to Bevin Feutrier; (bevin.feutrier@nih.gov). Offers shall include RFQ number in the subject line (RFQ-RML-D-1978596). Late submissions shall be treated in accordance with the solicitation provision at FAR 52.212-1(f)


All responsible sources may submit an offer that will be considered by this Agency.
Any questions or concerns regarding this solicitation should be forwarded in writing via e-mail to Bevin Feutrier @ bevin.feutrier@nih.gov.


.

Files

File Type Posted
RFQ_Supplemental.docx DOCX document
2_Line_Item_Description_and_Quantities.xlsx XLSX spreadsheet
2_1978596_52.212-5_Aug19_SAT.pdf PDF
Statement_of_Work_CSI_2019_WES_WGS_RNAseq_CNV.docx DOCX document
52.204-24_20190809.pdf PDF

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity